Fighting blindness with a minimally invasive retinal stimulator

视网膜退行性疾病是发达国家导致失明的主要原因，全世界有超过2亿人受到影响。我们团队首创了一种微创治疗性刺激器，可以在不阻碍视力的情况下阻止视网膜变性。我们现在已经准备好进行必要的翻译研究，以开发和测试人类级别的设备。最终目标是成为第一个开发出防止视力丧失的商业治疗性刺激器。

Retinal degenerative conditions are the leading cause of blindness in developed nations, with over 200 million people afflicted worldwide. Our group has pioneered a minimally-invasive therapeutic stimulator that can arrest retinal degeneration without blocking vision. We are now ready to perform the prerequisite translational studies to develop and test a human-grade device. The ultimate goal is to be the first to develop a commercial therapeutic stimulator that protects against vision loss.